Starting Strong: CLS Holdings USA, Inc. Announces January and February 2022 Results With Impressive Growth and Numbers
LAS VEGAS, NV / ACCESSWIRE / March 15, 2022 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'',...
Year: 2022
Avinger to Announce Full-Year 2021 Results on March 22
REDWOOD CITY, CA / ACCESSWIRE / March 15, 2022 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first...
Panacea Life Sciences, Inc. Partners with European CBD Market Leader, Chanelle McCoy Health for US Launch
GOLDEN, CO / ACCESSWIRE / March 15, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), (the "Company"), a cGMP certified, vertically...
CohBar to Announce 2021 Fourth Quarter and Full-Year Financial Results and Provide Business Update on March 29, 2022
Company to host conference call and webcast at 5:00 p.m. ETMENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- CohBar,...
New H1 Solution Sets Out to Transform How Patients Discover, Evaluate and Engage Doctors, While Helping Payors Solve for Provider Data Inaccuracy
Powered by H1's expansive provider-centric knowledge base, H1 Precise systematically updates and manages provider data for directory accuracy and network...
SeaSpine to Participate in the Canaccord Musculoskeletal Conference
CARLSBAD, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on...
Revelation Biosciences Inc. Announces Enrollment and Dosing Complete for Phase 2b Viral Challenge Study to Assess Efficacy of Intranasal REVTx 99 for the Prevention of H3N2 Influenza Infection
-Primary endpoint analysis expected early Q2 2022- -Final data expected Q2 2022- SAN DIEGO, March 15, 2022 (GLOBE NEWSWIRE) --...
Quoin Pharmaceuticals Announces Submission of IND for its Lead Asset, QRX003, for Netherton Syndrome
Quoin Anticipates Initiating Clinical Testing in Q2 2022ASHBURN, Va., March 15, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX)...
Sienna Announces March Dividend
MARKHAM, Ontario, March 15, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced...
Allarity Therapeutics Provides Update on Dovitinib Program
FOR IMMEDIATE RELEASE Allarity has requested a Type C meeting with the FDA to discuss potential clinical pathsto support approval...
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Wave Life Sciences to Highlight RNA Base Editing Modality and Alpha-1 Antitrypsin Deficiency Program at Upcoming Scientific and Industry Meetings
Presentation at OPT 2022 to highlight AATD program, including reduction of liver aggregates with repeat AIMer dosing out to 19...
Biomea Fusion to Present at Oppenheimer’s 32nd Annual Virtual Healthcare Conference
REDWOOD CITY, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to...
ALR Technologies Announces Completion of Pivotal Non-Inferiority Study on the GluCurve Pet CGM
SINGAPORE, March 15, 2022 (GLOBE NEWSWIRE) -- ALR Technologies Inc. (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company,...
Population Health Pioneer, AssureCare, to Showcase its Innovative Population Health Platform at HIMSS22
AssureCare’s connected care platform unifies payors, providers, and pharmacies to deliver patient-centric, coordinated careCINCINNATI, March 15, 2022 (GLOBE NEWSWIRE) --...
ExCellThera announces new data to be presented at the EBMT 2022 annual meeting
MONTRÉAL, March 15, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a clinical-stage cell expansion and engineering company delivering molecules and...
Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 22, 2022
BELGRADE, Mont., March 15, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company...
Caladrius Biosciences to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Tuesday, March 22, 2022, at 4:30 p.m. Eastern Time
BASKING RIDGE, N.J., March 15, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage...
Springs Rejuvenation Inc. Establishes Partnership with American Top Team Company
SPRJ Trainer George Mathews, Owner/head coach Roan "Jucao" Carneiro and Dr Charles PereyraAtlanta, GA, March 15, 2022 (GLOBE NEWSWIRE) --...
Mersana Therapeutics to Present an Analysis from the Expansion Cohort of the Phase 1 Trial of Upifitamab Rilsodotin at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and...